Amanote Research
Register
Sign In
Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder: Focus on Prophylactic Medication
doi 10.2174/9781681082158116010003
Full Text
Open PDF
Abstract
Available in
full text
Date
February 11, 2016
Authors
Unknown
Publisher
BENTHAM SCIENCE PUBLISHERS
Related search
Successful Use of Adjuvant Phytoestrogens in Schizoaffective Disorder
The Primary Care Companion to The Journal of Clinical Psychiatry
Visually Conceptualizing Psychoanalytic Resolution of Schizophrenia and Schizoaffective Disorder
International Journal of Psychiatry Research
The Effects of Psychoeducation on Long-Term Inpatients With Schizophrenia and Schizoaffective Disorder
Kurume Medical Journal
Medicine
Obvious Impairment of Attention and Processing Speed in Patients With Schizoaffective Disorder
Neuropsychiatry
Psychiatry
Mental Health
Neurology
Is Clinical Insight Associated With Working Memory Components in Schizophrenia and Schizoaffective Disorder?
Turk Psikiyatri Dergisi
Medicine
Psychiatry
Mental Health
Autonomic Control of the Heart: Going Beyond the Classical Neurotransmitters
Experimental Physiology
Nutrition
Physiology
Dietetics
Comparison of Two Intensities of Tobacco Dependence Counseling in Schizophrenia and Schizoaffective Disorder
Journal of Substance Abuse Treatment
Medicine
Clinical Psychology
Psychiatry
Psychiatric Mental Health
Mental Health
Prospective Trial of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic Medication in Homeless or Recently Homeless Individuals With Schizophrenia or Schizoaffective Disorder
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Liquid Chromatography-Mass Spectrometry Platform for Both Small Neurotransmitters and Neuropeptides in Blood, With Automatic and Robust Solid Phase Extraction
Scientific Reports
Multidisciplinary
